Academic Journal
Q1Journal of Alzheimer’s Disease
About Journal of Alzheimer’s Disease
Journal of Alzheimer's Disease is a scholarly journal published by SAGE Publications Ltd. SCImago 2025 lists it in Q1, with an SJR of 1.093 and H-index of 198.
Coverage: 1998-2026. Research categories: Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Geriatrics and Gerontology (Q2); Neuroscience (miscellaneous) (Q2); Psychiatry and Mental Health (Q2).
Source-backed journal facts
Topics in published research
Alzheimer's disease research and treatments; Dementia and Cognitive Impairment Research; Functional Brain Connectivity Studies; Neuroinflammation and Neurodegeneration Mechanisms; Neurological Disease Mechanisms and Treatments; Cholinesterase and Neurodegenerative Diseases.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Alterations in diacylglycerol kinase θ define early pathological features of Alzheimer's disease in a mouse model
Marika Lanza, Rossella Basilotta, Sarah Adriana Scuderi, Pietro Giovani et al.
2026-10-07 · DOI: 10.1177/13872877261490813White matter hyperintensities moderate neuropsychiatric response to N-acetylcysteine and exercise therapy in vascular mild cognitive impairment
Ethan Mah, Damien Gallagher, Yejin Kang, Fuqiang Gao et al.
2026-10-07 · DOI: 10.1177/13872877261490542Bazedoxifene restores myelin changes and attenuates cognitive deficits in a mouse model of Alzheimer's disease
Man-Yu Xu, Yu-Di Bai, Xiao-Qin Zeng, Cheng-Rong Tan et al.
2026-10-01 · DOI: 10.1177/13872877261490479Body mass index and mortality in incident dementia
Virginia W. Chang, Eleanor Hayes-Larson, Hui Zheng, Yuan S. Zhang et al.
2026-09-30 · DOI: 10.1177/13872877261491694Integrative transcriptomic and regulatory network analysis reveals associations of seven proposed risk genes with immune-related molecular features in Alzheimer's disease
Haimiao Yu, Wei Chang, Dilraba Mahmut, Chao Huang et al.
2026-09-30 · DOI: 10.1177/13872877261493169The role of neuroinflammation in the connections between autism spectrum disorder and Alzheimer's disease and related dementias: A review
Aleksandra K. Goncalo
2026-09-30 · DOI: 10.1177/13872877261491809WIMOAD: W eighted I ntegration of M ulti- O mics data with meta learning for A lzheimer's D isease diagnosis
Hanyu Xiao, Jieqiong Wang, Shibiao Wan
2026-09-30 · DOI: 10.1177/13872877261491975APOE4 is associated with lower adiposity independent of total energy intake in cognitively normal older adults
Aaron N. Smith, Chelsea N. Johnson, Matthew K. Taylor, Jessica E. Keller et al.
2026-09-30 · DOI: 10.1177/13872877261493064Use of multiple post-diagnostic dementia services across healthcare tiers in Beijing, China: A caregiver-reported cross-sectional study
Chenli Zhu, Haijin Li, Jingxuan Gao, Hui Li et al.
2026-09-30 · DOI: 10.1177/13872877261489615Economic model of Alzheimer's disease that incorporates the uncertainty associated with measuring efficacy in clinical trials
Javier Mar, Arantzazu Arrospide, Ron Handels, Myriam Soto-Gordoa et al.
2026-09-30 · DOI: 10.1177/13872877261490543Exploring the interplay between frailty, Alzheimer's disease biomarkers, and cognitive functioning in patients with mild cognitive impairment: A cross-sectional study
Manuela Pintus, Martina Valletta, Luca Sacchi, Tiziana Carandini et al.
2026-09-30 · DOI: 10.1177/13872877261487377Clinical and neuropathological aspects of canine cognitive dysfunction syndrome and a translational perspective for Alzheimer's disease
Evilly Lopes-Gomes, Fernando Francisco Borges Resende, Alexandra Mazer Greuel, Clara Luna Marina et al.
2026-09-30 · DOI: 10.1177/13872877261491819Religious order membership and cognitive function: Evidence for slower late-life decline despite higher incident dementia
Nwanyieze Ngozi Jiakponnah, Oluchukwu D. Biose, Iyinope Sivebukola, Chinaka J. Mbaeri et al.
2026-09-30 · DOI: 10.1177/13872877261490593Nonlinear association between waist-to-height ratio and Alzheimer's disease among middle-aged and older adults: A cross-sectional study from NHANES
Bei Li, Tianai Shi, Meidi Yang, Haijing Liu et al.
2026-09-30 · DOI: 10.1177/13872877261490818The efficacy of donepezil combination therapy strategies in Alzheimer's disease: A systematic review and network meta-analysis
Xinyue Ning, Yanmin Xiao, Nan Wang, Xinming Jiao et al.
2026-09-30 · DOI: 10.1177/13872877261491977Aging dogs exhibit heterogeneous cognitive decline trajectories: A longitudinal comparative model
Katherine E. Simon, Wojciech K. Panek, Gilad Fefer, Alejandra Mondino et al.
2026-09-29 · DOI: 10.1177/13872877261487575Accelerated biological aging in the association between early-life tobacco smoke exposure and dementia risk: An exploratory mediation analysis
Linling Yu, Huaxin Deng, Meng Yang, Ding-Sheng Jiang et al.
2026-09-29 · DOI: 10.1177/13872877261492699Immune boosting to combat Alzheimer's disease: Position statement
Peter Aaby, Steven E. Arnold, Christine Stabell Benn, Shay Ben-Haim et al.
2026-09-29 · DOI: 10.1177/13872877261472830Chronic mitochondrial DNA depletion alters MAPT splicing and increases tau levels
Ian Weidling, Emily Schueddig, Xiaowan Wang, Lesya Novikova et al.
2026-09-29 · DOI: 10.1177/13872877261492673A single-center open-label, randomized, parallel-group controlled clinical trial on the long-term effect of the treatment with EGb 761 in blood markers of inflammation and neurodegeneration in patients with mild cognitive impairment: ACE-2020-EGb 761
Xavier Morato, Marta Marquié, Juan Pablo Tartari, Asunción Lafuente et al.
2026-09-29 · DOI: 10.1177/13872877261490130Reviews
Community Reviews
Version History
October 4, 2026 at 8:57 pm
September 25, 2026